Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Psychiatric Quarterly
Published in: Psychiatric Quarterly 4/2013

01-12-2013 | Original Paper

Exercise Capacity and Quality of Life in Patients with Schizophrenia

Authors: Arno Kerling, Uwe Tegtbur, Marc Ziegenbein, Lena Grams, Dirk Robert Heinze, Marcel Sieberer

Published in: Psychiatric Quarterly | Issue 4/2013

Login to get access

Abstract

The aim of this study was to resolve the relationship between physical capacity (PC) and quality of life (Qol) in schizophrenic patients and healthy controls. 31 patients (PG: 18 male, 13 female) and a control group (CG) of 50 healthy subjects (15 male, 35 female) were involved. PC was assessed as peak oxygen uptake [VO2peak, (ml (min kgKG)−1)] and power output expressed as watts per kilogram (W kg−1). Qol was assessed using the SF-36 questionnaire. Patients with schizophrenia showed reduced VO2peak (male: PG 29 ± 5 vs. CG 44 ± 10; female: PG 21 ± 4 vs. CG 30 ± 8) and power output (male: PG 2.04 ± 0.47 vs. CG 3.43 ± 0.70; female PG 1.40 ± 0.28 vs. CG 2.43 ± 0.52). Scales of the SF-36 questionnaire were lower in the PG. While in the CG correlations were found between PC and several subscales of Qol, this was not the case in the PG. The restricted PC seen in the PG showed no relation to their subjectively assessed worsened Qol, which would indicate that schizophrenic patients evaluate limitations arising from this differently than healthy control subjects.
Literature
1.
Harris EC, Barraclough B: Excess mortality of mental disorder. The British Journal of Psychiatry 173:11–53, 1998.CrossRef
2.
Leucht S, Burkard T, Henderson J, Maj M, Sartorius N: Physical illness and schizophrenia: A review of the literature. Acta Psychiatrica Scandinavica 116(5):317–333, 2007.CrossRef
3.
Saha S, Chant D, McGrath J: A systematic review of mortality in schizophrenia: Is the differential mortality gap worsening over time? Archives of General Psychiatry 64(10):1123–1131, 2007.CrossRef
4.
Brown S, Kim M, Mitchell C, Inskip H: Twenty-five year mortality of a community cohort with schizophrenia. The British Journal of Psychiatry 196(2):116–121, 2010.CrossRef
5.
Tran E, Rouillon F, Loze JY, Casadebaig F, Philippe A, Vitry F, et al.: Cancer mortality in patients with schizophrenia: An 11-year prospective cohort study. Cancer 115(15):3555–3562, 2009.
6.
Wildgust HJ, Beary M: Are there modifiable risk factors which will reduce the excess mortality in schizophrenia? Journal of Psychopharmacology 24(4 Suppl):37–50, 2010.CrossRef
7.
Kodama S, Saito K, Tanaka S, Maki M, Yachi Y, Asumi M, et al.: Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: A meta-analysis. JAMA 301(19):2024–2035, 2009.CrossRef
8.
Blair SN: Physical inactivity: The biggest public health problem of the 21st century. British Journal of Sports Medicine 43(1):1–2, 2009.
9.
Brown S, Birtwistle J, Roe L, Thompson C: The unhealthy lifestyle of people with schizophrenia. Psychological Medicine 29(3):697–701, 1999.CrossRef
10.
Laursen TM, Munk-Olsen T, Agerbo E, Gasse C, Mortensen PB: Somatic hospital contacts, invasive cardiac procedures, and mortality from heart disease in patients with severe mental disorder. Archives of General Psychiatry 66(7):713–720, 2009.CrossRef
11.
Newcomer JW: Metabolic risk during antipsychotic treatment. Clinical Therapeutics 26(12):1936–1946, 2004.CrossRef
12.
Allison DB, Casey DE: Antipsychotic-induced weight gain: A review of the literature. The Journal of Clinical Psychiatry 62(Suppl 7):22–31, 2001.PubMed
13.
Alvarez-Jimenez M, Hetrick SE, Gonzalez-Blanch C, Gleeson JF, McGorry PD: Non-pharmacological management of antipsychotic-induced weight gain: Systematic review and meta-analysis of randomised controlled trials. The British Journal of Psychiatry 193(2):101–107, 2008.CrossRef
14.
Borg G: Borg’s Perceived Exertion and Pain Scales. Champaign, Human Kinetics, 1998.
15.
Löllgen H: Das Anstrengungsempfinden (RPE, Borg-Skala). Deutsche Zeitschrift für Sportmedizin 55(11): 299–300, 2004.
16.
Overall JE, Gorham DR: The brief psychiatric rating scale. Psychological Reports 10(3):799–812, 1962.CrossRef
17.
Bullinger M: Assessment of health related quality of life with the SF-36 Health Survey. Rehabilitation (Stuttg) 35(3):XVII–XXVII; quiz XXVII–XXIX, 1996.
18.
Ware JE Jr., Sherbourne CD: The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care 30(6):473–483, 1992.
19.
Leese M, Schene A, Koeter M, Meijer K, Bindman J, Mazzi M, et al.: SF-36 scales, and simple sums of scales, were reliable quality-of-life summaries for patients with schizophrenia. Journal of Clinical Epidemiology 61(6):588–596, 2008.CrossRef
20.
Pukrop R, Schlaak V, Moller-Leimkuhler AM, Albus M, Czernik A, Klosterkotter J, et al.: Reliability and validity of Quality of Life assessed by the Short-Form 36 and the Modular System for Quality of Life in patients with schizophrenia and patients with depression. Psychiatry Research 119(1–2):63–79, 2003.
21.
Nilsson BM, Olsson RM, Oman A, Wiesel FA, Ekselius L, Forslund AH: Physical capacity, respiratory quotient and energy expenditure during exercise in male patients with schizophrenia compared with healthy controls. European Psychiatry 27(3):206–212, 2012.CrossRef
22.
Deimel H, Lohmann S: Physical capacity of schizophrenic patients. Rehabilitation (Stuttg) 22(2):81–85, 1983.
23.
Dodd KJ, Duffy S, Stewart JA, Impey J, Taylor N: A small group aerobic exercise programme that reduces body weight is feasible in adults with severe chronic schizophrenia: a pilot study. Disability and Rehabilitation 33(13–14):1222–1229, 2011.PubMedCrossRef
24.
Strassnig M, Brar JS, Ganguli R: Low cardiorespiratory fitness and physical functional capacity in obese patients with schizophrenia. Schizophrenia Research 126(1–3):103–109, 2011.CrossRef
25.
Vancampfort D, Probst M, Sweers K, Maurissen K, Knapen J, De Hert M: Relationships between obesity, functional exercise capacity, physical activity participation and physical self-perception in people with schizophrenia. Acta Psychiatrica Scandinavica 123(6):423–430, 2011.CrossRef
26.
Hofer A, Kemmler G, Eder U, Edlinger M, Hummer M, Fleischhacker WW: Quality of life in schizophrenia: The impact of psychopathology, attitude toward medication, and side effects. The Journal of Clinical Psychiatry 65(7):932–939, 2004.CrossRef
27.
Schennach-Wolff R, Jager M, Obermeier M, Schmauss M, Laux G, Pfeiffer H, et al.: Quality of life and subjective well-being in schizophrenia and schizophrenia spectrum disorders: Valid predictors of symptomatic response and remission? The World Journal of Biological Psychiatry 11(5):729–738, 2010.CrossRef
28.
Allison DB, Mackell JA, McDonnell DD: The impact of weight gain on quality of life among persons with schizophrenia. Psychiatric Services 54(4):565–567, 2003.CrossRef
29.
Kolotkin RL, Corey-Lisle PK, Crosby RD, Swanson JM, Tuomari AV, L’italien GJ, et al.: Impact of obesity on health-related quality of life in schizophrenia and bipolar disorder. Obesity (Silver Spring) 16(4):749–754, 2008.
30.
Faulkner G, Cohn T, Remington G, Irving H: Body mass index, waist circumference and quality of life in individuals with schizophrenia. Schizophrenia Research 90(1–3):174–178, 2007.CrossRef
31.
Bronner M, Betz C, Christ S, Frobose T, Pitschel-Walz G, Bauml J: Wellness-activities to prevent metabolic syndrome among patients with schizophrenia. Psychiatrische Praxis 37(1):7–19, 2010.CrossRef
Metadata
Title
Exercise Capacity and Quality of Life in Patients with Schizophrenia
Authors
Arno Kerling
Uwe Tegtbur
Marc Ziegenbein
Lena Grams
Dirk Robert Heinze
Marcel Sieberer
Publication date
01-12-2013
Publisher
Springer US
Published in
Psychiatric Quarterly / Issue 4/2013
Print ISSN: 0033-2720
Electronic ISSN: 1573-6709
DOI
https://doi.org/10.1007/s11126-013-9256-4

Other articles of this Issue 4/2013

Psychiatric Quarterly 4/2013 Go to the issue

Original Paper

Associations Between Social Anxiety and Emotional Intelligence Within Clinically Depressed Patients

Original Paper

Morbidity and Mortality Associated with the Utilization of Restraints

Original Paper

Case Reports of Neuroleptic Malignant Syndrome in Context of Quetiapine Use

Original Paper

The Relationship Between Childhood Abuse and Psychosis for Women Prisoners: Assessing the Importance of Frequency and Type of Victimization

Original Paper

Measurement Methods of BDNF Levels in Major Depression: A Qualitative Systematic Review of Clinical Trials

Original Paper

Pharmacology and Pharmacogenetics of Pediatric ADHD with Associated Aggression: A Review